The Use of Zanubrutinib in Chronic Lymphocytic Leukemia
Publication
, Journal Article
Brander, DM
Published in: Clinical Advances in Hematology and Oncology
December 1, 2022
Duke Scholars
Published In
Clinical Advances in Hematology and Oncology
ISSN
1543-0790
Publication Date
December 1, 2022
Volume
20
Issue
12
Start / End Page
1 / 4
Related Subject Headings
- Oncology & Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Brander, D. M. (2022). The Use of Zanubrutinib in Chronic Lymphocytic Leukemia. Clinical Advances in Hematology and Oncology, 20(12), 1–4.
Brander, D. M. “The Use of Zanubrutinib in Chronic Lymphocytic Leukemia.” Clinical Advances in Hematology and Oncology 20, no. 12 (December 1, 2022): 1–4.
Brander DM. The Use of Zanubrutinib in Chronic Lymphocytic Leukemia. Clinical Advances in Hematology and Oncology. 2022 Dec 1;20(12):1–4.
Brander, D. M. “The Use of Zanubrutinib in Chronic Lymphocytic Leukemia.” Clinical Advances in Hematology and Oncology, vol. 20, no. 12, Dec. 2022, pp. 1–4.
Brander DM. The Use of Zanubrutinib in Chronic Lymphocytic Leukemia. Clinical Advances in Hematology and Oncology. 2022 Dec 1;20(12):1–4.
Published In
Clinical Advances in Hematology and Oncology
ISSN
1543-0790
Publication Date
December 1, 2022
Volume
20
Issue
12
Start / End Page
1 / 4
Related Subject Headings
- Oncology & Carcinogenesis